Syros Pharmaceuticals Inc. Stock, NASDAQ:SYRS
35 CambridgePark Drive, 4th floor, Cambridge, Massachusetts 02140
United States of America
Number of Employees: 103
Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.